White matter hyperintensities in cholinergic pathways are associated with dementia severity in e4 carriers but not in non-carriers
Authors:
Open Access
- 14 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1100322
Abstract
Background and objectives: Among individuals with Alzheimer's disease (AD), APOE e4 carriers with increased white matter hyperintensities (WMHs) may selectively be at increased risk of cognitive impairment. Given that the cholinergic system plays a crucial role in cognitive impairment, this study aimed to identify how APOE status modulates the associations between dementia severity and white matter hyperintensities in cholinergic pathways.Methods: From 2018 to 2022, we recruited participants (APOE e4 carriers, n = 49; non-carriers, n = 117) from the memory clinic of Cardinal Tien Hospital, Taipei, Taiwan. Participants underwent brain MRI, neuropsychological testing, and APOE genotyping. In this study, we applied the visual rating scale of the Cholinergic Pathways Hyperintensities Scale (CHIPS) to evaluate WMHs in cholinergic pathways compared with the Fazekas scale. Multiple regression was used to assess the influence of CHIPS score and APOE carrier status on dementia severity based on Clinical Dementia Rating—Sum of Boxes (CDR-SB).Results: After adjusting for age, education and sex, higher CHIPS scores tended to be associated with higher CDR-SB in APOE e4 carriers but not in the non-carrier group.Conclusions: Carriers and non-carriers present distinct associations between dementia severity and WMHs in cholinergic pathways. In APOE e4 carriers, increased white matter in cholinergic pathways are associated with greater dementia severity. In non-carriers, WMHs exhibit less predictive roles for clinical dementia severity. WMHs on the cholinergic pathway may have a different impact on APOE e4 carriers vs. non-carriers.Keywords
This publication has 53 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- White matter hyperintensities segmentation: a new semi-automated methodFrontiers in Aging Neuroscience, 2013
- Plasma Signaling Proteins in Persons at Genetic Risk for Alzheimer DiseaseArchives of Neurology, 2012
- Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive statusJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer diseaseNeurology, 2008
- Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes ScoresArchives of Neurology, 2008
- Classification of White Matter Lesions on Magnetic Resonance Imaging in Elderly PersonsBiological Psychiatry, 2008
- The significance of the cholinergic system in the brain during aging and in Alzheimer’s diseaseJournal of Neural Transmission, 2006
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993